| RIFAXIMIN |
214369 |
001 |
ANDA |
RIFAXIMIN |
TABLET;ORAL |
550MG |
No
|
No
|
2024/06/20
(TA)
|
--
|
NORWICH PHARMACEUTICALS INC |
None (Tentative Approval) |
| RIFAXIMIN |
214370 |
001 |
ANDA |
RIFAXIMIN |
TABLET;ORAL |
200MG |
No
|
No
|
2025/01/10
(TA)
|
--
|
NORWICH |
None (Tentative Approval) |
| RIFAXIMIN |
213713 |
001 |
ANDA |
RIFAXIMIN |
TABLET;ORAL |
550MG |
No
|
No
|
2025/05/29
(TA)
|
--
|
SANDOZ INC |
None (Tentative Approval) |
| RIFAXIMIN |
218650 |
002 |
ANDA |
RIFAXIMIN |
TABLET |
200MG |
No
|
No
|
2025/05/30
(TA)
|
--
|
ZYDUS PHARMS USA INC |
None (Tentative Approval) |
| RIFAXIMIN |
219570 |
002 |
ANDA |
RIFAXIMIN |
TABLET |
200MG |
No
|
No
|
2025/12/08
(TA)
|
--
|
CIPLA LTD |
None (Tentative Approval) |